Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk.
binding proteins
cancer
cross-talk
growth factors
insulin
mechanism
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
09
01
2020
accepted:
16
04
2020
entrez:
6
6
2020
pubmed:
6
6
2020
medline:
6
6
2020
Statut:
epublish
Résumé
The insulin/insulin-like growth factors (IGFs) have crucial tasks in the growth, differentiation, and proliferation of healthy and pernicious cells. They are involved in coordinated complexes, including receptors, ligands, binding proteins, and proteases. However, the systems can become dysregulated in tumorigenesis. Insulin-like growth factor-binding protein 7 (IGFBP7) is a protein belonging to the IGFBP superfamily (also termed GFBP-related proteins). Numerous studies have provided evidence that IGFBP3 and IGFBP7 are involved in a variety of cancers, including hepatocellular carcinoma (HCC), breast cancer, gastroesophageal cancer, colon cancer, prostate cancer, among many others. Still, very few suggest an interaction between these two molecules. In studying several cancer types in our laboratories, we found that both proteins share some crucial signaling pathways. The objective of this review is to present a comprehensive overview of the relationship between IGFBP7 and cancer, as well as highlighting IGFBP3 crosstalk with IGFBP7 reported in recent studies.
Identifiants
pubmed: 32500027
doi: 10.3389/fonc.2020.00727
pmc: PMC7242731
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
727Informations de copyright
Copyright © 2020 Jin, Shen, Weinfeld and Sergi.
Références
Endocrinology. 2000 Nov;141(11):4072-80
pubmed: 11089538
Biochem Biophys Res Commun. 2004 Jan 30;314(1):83-8
pubmed: 14715249
J Am Soc Nephrol. 2016 Sep;27(9):2645-57
pubmed: 26839368
Cell Death Dis. 2015 Mar 19;6:e1695
pubmed: 25789970
Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6152-8
pubmed: 15448002
Breast Cancer Res Treat. 2012 Jun;133(2):563-73
pubmed: 21997538
Cancer Biol Ther. 2011 Oct 1;12(7):634-46
pubmed: 21795858
Prog Growth Factor Res. 1995;6(2-4):273-84
pubmed: 8817670
Anticancer Res. 2016 Sep;36(9):4391-8
pubmed: 27630274
Science. 2000 Aug 18;289(5482):1197-202
pubmed: 10947988
Breast Cancer Res Treat. 2011 Apr;126(2):373-84
pubmed: 20464481
Oncotarget. 2018 May 25;9(40):25983-25992
pubmed: 29899836
PLoS One. 2010 Nov 30;5(11):e15074
pubmed: 21152079
J Urol. 2012 Oct;188(4):1354-60
pubmed: 22906661
Cancer Sci. 2007 Jul;98(7):1055-63
pubmed: 17465992
Endocr Relat Cancer. 2004 Mar;11(1):141-8
pubmed: 15027891
Cancer Biol Ther. 2012 Feb 1;13(3):148-55
pubmed: 22277373
J Pathol. 2007 May;212(1):83-90
pubmed: 17334979
Biochem Biophys Res Commun. 2000 Jan 7;267(1):109-17
pubmed: 10623583
Breast Cancer Res Treat. 2009 May;115(1):151-62
pubmed: 18481170
Growth Horm IGF Res. 2002 Aug;12(4):193-7
pubmed: 12175651
Neoplasia. 2008 Dec;10(12):1335-42
pubmed: 19048112
Microarrays (Basel). 2016 Jul 08;5(3):
pubmed: 27600085
Prostate. 2003 Jul 1;56(2):115-22
pubmed: 12746836
Endocr Rev. 1999 Dec;20(6):761-87
pubmed: 10605625
BMC Cancer. 2015 Oct 08;15:663
pubmed: 26450156
Biochem Biophys Res Commun. 2007 Jun 8;357(3):785-91
pubmed: 17451653
J Histochem Cytochem. 2000 Jun;48(6):747-54
pubmed: 10820148
PLoS One. 2016 Mar 14;11(3):e0150897
pubmed: 26974954
Cancer Lett. 2003 Jun 10;195(2):127-37
pubmed: 12767520
Cancer Lett. 2002 Feb 25;176(2):149-58
pubmed: 11804742
Genes Chromosomes Cancer. 2014 Jan;53(1):90-7
pubmed: 24142767
Anticancer Res. 2009 Jul;29(7):2579-87
pubmed: 19596932
Cancer Res. 2003 May 15;63(10):2569-77
pubmed: 12750281
J Int Med Res. 2014 Jun;42(3):651-8
pubmed: 24743871
Cancer Res. 2017 Aug 1;77(15):4014-4025
pubmed: 28619711
J Biol Chem. 1997 Dec 5;272(49):30729-34
pubmed: 9388210
J Exp Clin Cancer Res. 2011 Sep 26;30:87
pubmed: 21943236
J Biol Chem. 2000 Oct 27;275(43):33607-13
pubmed: 10874028
J Biol Chem. 1996 Nov 29;271(48):30322-5
pubmed: 8939990
FEBS J. 2006 Feb;273(3):615-27
pubmed: 16420484
Cancer Res. 2010 Apr 1;70(7):2870-9
pubmed: 20215521
Clin Chim Acta. 2017 Mar;466:172-177
pubmed: 28104361
J Cell Physiol. 2000 Apr;183(1):1-9
pubmed: 10699960
PLoS One. 2017 Apr 17;12(4):e0176096
pubmed: 28414818
Glia. 2007 Apr 15;55(6):559-72
pubmed: 17266141
Anticancer Res. 2007 Sep-Oct;27(5B):3513-8
pubmed: 17972510
Int J Cancer. 2000 Aug 1;87(3):373-8
pubmed: 10897042
Br J Cancer. 2008 Oct 21;99(8):1307-15
pubmed: 18827816
Mol Cancer. 2010 Oct 26;9:281
pubmed: 20977730
Br J Cancer. 2014 Feb 4;110(3):775-82
pubmed: 24357797
Cancer Biol Ther. 2007 Mar;6(3):354-9
pubmed: 17312390
J Clin Endocrinol Metab. 2002 Jan;87(1):271-6
pubmed: 11788658
Mol Cancer. 2017 Jan 30;16(1):6
pubmed: 28137302
Mol Cancer Res. 2005 Mar;3(3):119-29
pubmed: 15798092
Cancer Biol Ther. 2011 Jul 1;12(1):69-79
pubmed: 21525788
Clin Cancer Res. 2011 Nov 1;17(21):6693-701
pubmed: 21908579
Mol Cancer Ther. 2009 Nov;8(11):3009-14
pubmed: 19861408
J Clin Lab Anal. 1999;13(4):166-72
pubmed: 10414596
Int J Oncol. 2017 Feb;50(2):622-630
pubmed: 28035363
Ann Clin Lab Sci. 2015 Winter;45(1):3-9
pubmed: 25696003
J Clin Invest. 2008 Jul;118(7):2609-19
pubmed: 18568074
Sci Signal. 2012 Dec 18;5(255):ra92
pubmed: 23250396
Endocr Rev. 2002 Dec;23(6):824-54
pubmed: 12466191
World J Gastroenterol. 2001 Oct;7(5):726-31
pubmed: 11819864
Gastroenterology. 2006 Sep;131(3):925-33
pubmed: 16952561
Int J Cancer. 2001 Jul 20;95(4):216-22
pubmed: 11400113
J Clin Pathol. 2015 Oct;68(10):795-801
pubmed: 26043748
Nat Rev Cancer. 2012 Feb 16;12(3):159-69
pubmed: 22337149
Mol Cell Biochem. 2008 Jan;307(1-2):221-36
pubmed: 17899320
Clin Endocrinol (Oxf). 2006 May;64(5):479-80
pubmed: 16649963
Cancer Lett. 2017 May 1;393:76-85
pubmed: 28223169
Eur J Cancer. 2005 Jul;41(11):1515-27
pubmed: 15979304
Front Endocrinol (Lausanne). 2019 Mar 01;10:93
pubmed: 30881341
Breast Cancer Res. 2007;9(1):R2
pubmed: 17210081
Br J Cancer. 2010 May 11;102(10):1483-90
pubmed: 20407444
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8384-9
pubmed: 8710880
J Biol Chem. 2000 Dec 15;275(50):39174-81
pubmed: 10998426
J Med Chem. 2019 Jan 24;62(2):480-490
pubmed: 30571119
J Exp Clin Cancer Res. 2010 Apr 30;29:41
pubmed: 20433702
Oncogene. 2015 Feb 12;34(7):815-25
pubmed: 24632618
Cancer Biol Ther. 2010 Oct 15;10(8):796-810
pubmed: 20686364
J Biol Chem. 1999 Mar 12;274(11):6935-45
pubmed: 10066747
J Exp Clin Cancer Res. 2010 Feb 16;29:13
pubmed: 20158915
Cancer Res. 1999 May 15;59(10):2370-5
pubmed: 10344746
J Clin Endocrinol Metab. 1998 Dec;83(12):4355-62
pubmed: 9851777
Endocrinology. 1997 Jun;138(6):2280-5
pubmed: 9165012
Oncogene. 2008 Nov 20;27(54):6834-44
pubmed: 18711401
Cancer Res. 2006 May 15;66(10):5021-8
pubmed: 16707423
Cancer Res. 1999 Jun 15;59(12):2787-90
pubmed: 10383131
J Cancer Res Clin Oncol. 2012 Jun;138(6):1045-55
pubmed: 22392074
Neuro Oncol. 2012 Jan;14(1):53-63
pubmed: 22013169
Cancer Res. 2003 Nov 15;63(22):7717-23
pubmed: 14633696
J Biol Chem. 2000 Dec 15;275(50):39146-51
pubmed: 10993898
Sci Rep. 2017 Jan 12;7:40138
pubmed: 28079144
Mol Med Rep. 2009 Nov-Dec;2(6):971-6
pubmed: 21475929
J Cell Biochem. 1999 Nov 1;75(2):187-95
pubmed: 10502291
Mol Biol Cell. 2003 Nov;14(11):4569-80
pubmed: 12937269
Front Biosci. 2008 May 01;13:3273-87
pubmed: 18508432
J Cancer Res Clin Oncol. 2007 May;133(5):305-14
pubmed: 17136345
Proc Natl Acad Sci U S A. 1995 May 9;92(10):4472-6
pubmed: 7538673
J Clin Endocrinol Metab. 2019 Mar 1;104(3):665-673
pubmed: 30137347
Ann Intern Med. 2008 Oct 7;149(7):461-71, W83-8
pubmed: 18838726
Cancer Res. 2006 Mar 15;66(6):3024-33
pubmed: 16540651
Oncotarget. 2016 Sep 6;7(36):58162-58173
pubmed: 27528224
Br J Cancer. 2010 Nov 9;103(10):1606-16
pubmed: 20959824
Zhonghua Bing Li Xue Za Zhi. 2008 Aug;37(8):512-6
pubmed: 19094461
Oncol Rep. 2019 Nov;42(5):1935-1945
pubmed: 31545454
Cell. 2008 Feb 8;132(3):363-74
pubmed: 18267069
Cell Growth Differ. 2002 May;13(5):205-13
pubmed: 12065244
J Pathol. 2007 Mar;211(4):431-8
pubmed: 17236181
Lung Cancer. 2011 Jul;73(1):38-44
pubmed: 21095038
J Biol Chem. 2002 Mar 1;277(9):7255-61
pubmed: 11751851
Oncogene. 2001 Jun 14;20(27):3497-505
pubmed: 11429696
Annu Rev Genet. 1985;19:463-84
pubmed: 3909947
Cell. 2010 May 14;141(4):717-27
pubmed: 20478260
Breast Cancer Res Treat. 2008 Jan;107(2):181-94
pubmed: 17611793
Tumour Biol. 2014 Sep;35(9):8875-81
pubmed: 24894674
Cancer Res. 2003 Dec 1;63(23):8248-55
pubmed: 14678982
Cancer Biomark. 2012-2013;12(1):1-9
pubmed: 23321464
Int J Cancer. 2007 Feb 1;120(3):566-73
pubmed: 17096329
Mol Cell Proteomics. 2018 Feb;17(2):270-289
pubmed: 29141914
Cancer. 2006 Jul 15;107(2):299-308
pubmed: 16773633
J Clin Endocrinol Metab. 2003 Jul;88(7):3401-8
pubmed: 12843194
Prog Growth Factor Res. 1995;6(2-4):357-66
pubmed: 8817679
J Natl Cancer Inst. 2000 Sep 20;92(18):1472-89
pubmed: 10995803
J Cell Physiol. 2009 Jul;220(1):182-8
pubmed: 19259947
Front Endocrinol (Lausanne). 2014 Feb 04;5:10
pubmed: 24550888
Oncogene. 2002 Jan 3;21(1):140-7
pubmed: 11791184
Biochem Biophys Res Commun. 2004 Dec 24;325(4):1194-200
pubmed: 15555553
Biomed Res Int. 2015;2015:638526
pubmed: 26221601
Cancer Res. 2004 Jan 15;64(2):665-71
pubmed: 14744783
Blood. 2004 Jul 1;104(1):237-42
pubmed: 15026318
Oncogene. 1998 May 14;16(19):2459-67
pubmed: 9627112
Front Endocrinol (Lausanne). 2012 Mar 02;3:38
pubmed: 22654863
Int J Biochem Cell Biol. 1996 Jun;28(6):619-37
pubmed: 8673727
Front Endocrinol (Lausanne). 2018 Apr 09;9:117
pubmed: 29686648
Mol Med. 2000 Feb;6(2):126-35
pubmed: 10859029